Phase 4Not yet recruitingHealthspan endpoint
StAtins in Frail OldEr Patients with Ischemic Stroke or Transient Ischemic Attack - the Randomized Controlled Trial (SAFEST - RCT)
- Sponsor
- Prof. dr. Nathalie van der Velde (Academic or other)
- Enrollment
- 612 planned
- Conditions
- Ischemic Stroke; Transient Ischemic Attack
- Interventions
- Statin (atorvastatin, fluvastatin, pravastatin, rosuvastatin or simvastatin)
- Ages
- older adults
- Registry
- NCT06785727
Full record on ClinicalTrials.gov
From the registry
Two Dutch guidelines (Stroke and Cardiovascular Risk Management) provide conflicting advice on optimal statin treatment in older patients. In the SAFEST - RCT, the investigators will assess the impact of starting versus not starting a statin in frail individuals aged 70 and above with a recent ischemic stroke or transient ischemic attack (TIA) on their health-related quality of life and Major Adverse Cardiovascular Events (MACE) free survival during a two-year follow-up period.
Primary outcomes
- Health-Related Quality of Life (HrQoL)
- Major Adverse Cardiovascular Events (MACE) free survival
History
Study completion expected
Primary completion expected
Started
Registered